Your browser doesn't support javascript.
loading
Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
Razavian, Niema B; D'Agostino, Ralph B; Shenker, Rachel F; Hughes, Ryan T.
Afiliación
  • Razavian NB; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina.
  • D'Agostino RB; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, North Carolina.
  • Shenker RF; Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.
  • Hughes RT; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina. Electronic address: ryhughes@wakehealth.edu.
Int J Radiat Oncol Biol Phys ; 117(3): 652-663, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37150263
PURPOSE: Early-stage squamous cell carcinoma of the glottic larynx is commonly treated with 2-dimensional or 3-dimensional conventional radiation therapy (CRT). Despite its use in other head and neck cancers, intensity-modulated radiation therapy (IMRT) remains controversial in this patient population. METHODS AND MATERIALS: A systematic review was performed by querying 3 databases (Pubmed, Embase, Web of Science) for articles published between December 1, 2000 and September 2, 2022. Included studies reported outcomes in at least 10 patients treated with IMRT for early-stage glottic cancer. Data were extracted and reported following PRISMA standards. Pooled outcomes were estimated using random-effects models. Primary outcome was the rate of local failure (LF) following IMRT. Secondary outcomes included rates of regional failure (RF) following IMRT and rates of LF and RF following CRT. RESULTS: A total of 15 studies (14 retrospective, 1 prospective) consisting of 2083 patients were identified. IMRT was used in 873 patients (64% T1, 28% T2). Multiple treatment (partial larynx, single vocal cord carotid sparing) and image-guided radiation therapy techniques were used. The pooled crude rate of LF was 7.6% (95% confidence inverval [CI], 3.6%-11.5%) and actuarial LF rates at 3 and 5 years were 6.3% (95% CI, 2.2%-10.3%) and 9.0% (95% CI, 4.4%-13.5%), respectively. The pooled crude rate of RF after IMRT was 1.5% (95% CI, 0.5%-2.5%). On metaregression analysis, increased rate of LF was significantly associated with T2 disease (P < .001) and grade 2 to 3 histology (P < .001). Treatment with CRT was reported in 738 patients (76% T1, 22% T2). Among the studies reporting outcomes of both modalities, there was no significant difference in LF (log odds ratio; P = .12) or RF (log odds ratio; P = .58) between IMRT or CRT. CONCLUSIONS: In patients with early-stage glottic cancer, retrospective data suggests local and regional control are similar for patients treated with IMRT and CRT. Additional prospective studies with uniform methods of volume delineation and image guidance are needed to confirm the efficacy of IMRT.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Laríngeas / Radioterapia de Intensidad Modulada Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Laríngeas / Radioterapia de Intensidad Modulada Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article